XLO XILIO THERAPEUTICS INC Management Changes 8-K Filing 2023 - Appointment of Principal Financial and Accounting Officer Xilio Therapeutics, Inc. appointed Kevin Brennan as Senior Vice President, Finance and Accounting, and adopted amended and restated bylaws.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC